Aillis was selected as one of the [90+ Artificial Intelligence Startups In Healthcare] by CB Insights.

Aillis was introduced on NIKKEI MJ.

Our CEO, Sho Okiyama, participated in a panel discussion titled "Building an effective HealthTech CEO Covid-19 survival strategy" by Galen Growth.

Our CEO, Sho Okiyama, was interviewed by NIKKEI STYLE.

Our CSO, Hiroaki Kato, was interviewed by Japanese Cabinet Office National Strategic Special Zones.

Our CSO, Hiroaki Kato, has been re-elected as a councilor of the Japanese Society of Artificial Intelligence in Ophthalmology.

Our CSO, Hiroaki Kato, has been reappointed as Clinical Associate Professor of Tokyo Medical and Dental University.

Our CSO, Hiroaki Kato, has been reappointed as Visiting Associate Professor of Chiba University Hospital.

Our CSO, Hiroaki Kato, has been reappointed as a part-time lecturer of Yokohama City University.

Our CSO, Hiroaki Kato, has been reappointed as a part-time lecturer of the Graduate School of Tohoku University.

Yoshihiro Todoroki and Miho Nakamura were interviewed by Japan Medical Planning.

Our CEO, Sho Okiyama, was interviewed by Recruit Doctor's Career.

Our Executive Officer, Yasufumi Sakiji, was interviewed by ASCII.jp.

Our CSO, Hiroaki Kato, gave a presentation at Aomori Life Innovation Forum.

Our CSO, Hiroaki Kato, gave a presentation at Japan Medical Association.

Our CEO, Sho Okiyama, gave a presentation at Japan Municipal Hospital Association.

Aillis ranked #3 in Degital Health Startup Rankings by Nikkei Degital Health.

Our CSO, Hiroaki Kato, served as a judge at Japan Healthcare Business Competition 2020 held by METI.

Our CTO, Atsushi Fukuda, was interviewed by AIST about AI Bridging Cloud Infrastructure (ABCI).